Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Coherus Biosciences (CHRS) Q4 2022 Earnings
CHRS
6
Mar
Confirmed
May 22
Aug 22
Nov 22
Q4 2022
-1
-0.82
-0.65
-0.47
Details
Expected EPS
-0.84
Actual EPS
-0.6
Surprise EPS
0.24
Surprise Percent
+28.57%
Description
Coherus Biosciences (CHRS) has reported earnings of -0.6 per share for Q4 2022.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login